Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70

被引：57
作者：
Anekonda T.S. [1 ]
Adamus G. [1 ]
机构：
[1] Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland
来源：
BMC Research Notes | / 1卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Resveratrol; Thapsigargin; Retinal Cell; Retinal Degeneration; Sirt1 Expression;
D O I：
10.1186/1756-0500-1-122
中图分类号：
学科分类号：
摘要：
Background. To determine whether resveratrol, a natural plant-derived drug, has protective effects against antibody-induced apoptosis of retinal cells in vitro and to provide insights on the mechanism of resveratrol protection. Findings. E1A.NR3 retinal cells pretreated with 40 M resveratrol were grown in the presence of anti-recoverin (Rec-1), anti-enolase (Enol-1) antibodies, and normal purified immunoglobulins. When the cells were exposed to resveratrol before treatment with Enol-1 or Rec-1 antibodies, 30-55% more cells survived compared to the resveratrol-untreated cells. Western blotting showed a reduction in proapoptotic protein Bax in the cytoplasm and mitochondria of resveratrol-treated cells. Resveratrol-pretreated cells also showed a significant decrease in intracellular calcium and an inhibition of caspase-3 activity as compared to the untreated cells. Sirt1 expression was greatly reduced in the cells grown in the presence of Rec-1 and Enol-1, but it increased about five times in the resveratrol-pretreated cells. Immunocytochemistry revealed that Sirt1 expression in the cytoplasm and nucleus was colocalized with Ku70 expression in resveratrol-treated cells, suggesting possible interaction with each other in the cell. The pattern of the Ku70 cellular localization also overlapped with the Bax cellular localization in treated and untreated cells. Conclusion. In vitro protection of retinal cells from apoptosis by resveratrol occurred through multiple early molecular events, such as reduction of intracellular calcium levels, down-regulation of Bax, up-regulation of Sirt1 and Ku70 activities, and inhibition of caspase-3 activity. These findings will help designing future in vivo and pre-clinical treatments for autoimmune retinopathies. © 2008 Anekonda et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 27 条
  • [1] Keltner J.L., Thirkill C.E., Tyler N.K., Roth A.M., Management and monitoring of cancer-associated retinopathy, Arch Ophthalmol, 110, 1, pp. 48-53, (1992)
  • [2] Congdon N., Causes and Prevalence of Visual Impairment among Adults in the United States, Archives of Ophthalmology, 122, 4, pp. 477-485, (2004)
  • [3] Weleber R.G., Watzke R.C., Shults W.T., Trzupek K.M., Heckenlively J.R., Egan R.A., Adamus G., Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies, Am J Ophthalmol, 139, 5, pp. 780-794, (2005)
  • [4] Thirkill C.E., Roth A.M., Keltner J.L., Cancer-associated retinopathy, Arch Ophthalmol, 105, 3, pp. 372-375, (1987)
  • [5] Adamus G., Ren G., Weleber R.G., Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy, BMC Ophthalmol, 4, (2004)
  • [6] Magrys A., Anekonda T., Ren G., Adamus G., The Role of Anti-alpha-Enolase Autoantibodies in Pathogenicity of Autoimmune-Mediated Retinopathy, J Clin Immunol, (2007)
  • [7] Adamus G., Guy J., Schmied J.L., Arendt A., Hargrave P.A., Role of anti-recoverin autoantibodies in cancer-associated retinopathy, Invest Ophthalmol Vis Sci, 34, 9, pp. 2626-2633, (1993)
  • [8] Maeda A., Maeda T., Ohguro H., Palczewski K., Sato N., Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice, Eur J Immunol, 32, 8, pp. 2300-2307, (2002)
  • [9] Shiraga S., Adamus G., Mechanism of CAR syndrome: Anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway, J Neuroimmunol, 132, 1-2, pp. 72-82, (2002)
  • [10] Parker J.A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H., Neri C., Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons, Nat Genet, 37, 4, pp. 349-350, (2005)
123